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Background: We analyzed the causes and results of utilization of critical care
services in the special care unit in patients after surgical procedures performed
by the hepatobiliary surgical service during a 23-month period.
Results: Thirty-two of 537 patients (6.0%) required postoperative admission to
the special care unit. Twenty-one patients were admitted directly from operating
room or from recovery room because of inability to wean from ventilator (n = 10),
hypovolemic shock (n = 4), myocardial ischemia or infarction (n = 2), sepsis
(n = 2), upper gastrointestinal bleeding (n = 2), and acute renal failure (n = 1).
Eleven postoperative patients were admitted from floor care for respiratory failure
(n = 4), cardiac dysrhythmia or infarction (n = 4), sepsis (n = 2), and upper
gastrointestinal bleeding (n = 1). Thirty-eight per cent of patients (n = 12)
admitted to the special care unit after surgery died. By multivariate analysis, total
postoperative stay in the special care unit that was greater than median total
duration of stay of 4.5 days was the only independent predictor of mortality
(P = 0.041).
Conclusions: Respiratory failure was the predominant component of all
complications after hepatobiliary surgery. No clinically useful predictors of
eventual outcome could be identified.
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Introduction
Postoperative morbidity and mortality after hepatobiliary
operations, especially in cancer patients, has traditionally
been perceived as being high. Prior reports, however,
have failed to identify a predominant class of complica-
tions, such that interventions could be undertaken that
might be able to reduce the incidence of these complica-
tions. Prior reports have focused on subgroups of opera-
tions within the family of all hepatobiliary procedures,
such as hepatic resection [1–5], proximal bile duct resec-
tion [6,7], pancreatic resection [8,9], and biliary–enteric
bypass [10]. There are no prior reports on the utilization
and outcomes of critical care services required in the man-
agement of all patients who experience complications
after hepatobiliary surgery at a single institution. This
paper reviews the complications leading to the utilization
of critical care services after all hepatobiliary procedures
performed over a 23-month period by a team of special-
ized surgeons, nurses, anesthesiologists, and internists
who comprise the Hepatobiliary Disease Management
Team of the Memorial Sloan-Kettering Cancer Center.
Materials and methods
Between February 2, 1994 and December 28, 1995, all
patients admitted to the Hepatobiliary Surgical Service at
Memorial Sloan-Kettering Cancer Center were identified
from the institutional database and the hepatobiliary data-
base. For these patients, the following variables were col-
lected from the Institutional Database: admitting diagnosis,
operative procedure(s) performed, whether admission to
SCU = special care unit; PACU = postanesthesia care unit.
the special care unit (SCU) was required, and outcome. For
all patients undergoing hepatobiliary surgical procedures
and admitted to the SCU during their hospital course, mul-
tiple preoperative, intraoperative, and postoperative vari-
ables were collected by retrospective chart review.
Patients undergoing hepatic, biliary, or pancreatic resec-
tion by the Hepatobiliary Surgical Service are routinely
monitored during emergence from anesthesia in the
postanesthesia care unit (PACU) for the first postoperative
night, and, if stable the following morning, are transferred
to floor care for further postoperative care. In this study,
time in the PACU was not counted as utilization of the
critical care services. Total duration of SCU stay was
defined as the total number of days (consecutive or non-
consecutive) spent in the SCU during a hospital admis-
sion. Postoperative death was defined as death within 30
days postoperatively or before discharge from the hospital.
Statistical analysis
Results are expressed as the means±standard deviation,
median (range), or as the number and percentage of the
total number of patients for categoric variables. One-way
analysis of variance was used for comparison of all continu-
ous variables. Pearson’s χ2 analysis or Fisher’s exact test,
when appropriate, were used for univariate comparisons
for all categoric variables analyzed. When multiple cate-
goric variables were determined to be statistically signifi-
cant by univariate analysis, they were then entered into a
logistic regression model for multivariate analysis to deter-
mine independent predictors of outcome. The software
program SPSS for Windows (version 8.0; SPSS Incorpo-
rated, Chicago, Illinois, USA) was utilized for all statistical
analyses. P≤0.05 was considered statistically significant.
Results
Study population
Between February 2, 1994 and December 28, 1995, 1048
patients were admitted to the Hepatobiliary Surgical
Service (admitting physicians LHB and YF) at Memorial
Sloan-Kettering Cancer Center. Of these, 32 out of 537
patients (6.0%) undergoing surgical treatment were admit-
ted to the SCU, whereas four out of 511 patients (0.8%)
who were receiving medical treatment only were admitted
to the SCU. No single surgical procedure was associated
with a higher frequency of SCU utilization than other pro-
cedures (data not shown).
Preoperative variables
The mean age of the 32 patients (22 males, 10 females)
admitted to the SCU for postoperative care was
63.2±12.2years (median 66years, range 30–84years). The
admitting diagnoses are summarized in Table 1. Eighteen
patients had a history of cardiac disease, 10 were jaun-
diced in the preoperative period, 10 underwent preopera-
tive biliary instrumentation, nine underwent preoperative
biliary drainage, five had a history of cirrhosis and/or portal
hypertension, four had a history of chronic obstructive pul-
monary disease, and three had a history of viral hepatitis.
Mean preoperative laboratory values of those 32 patients
admitted to the SCU for postoperative care were as
follows: albumin 3.5±0.7g/dl (normal range 4.0–5.2g/dl),
prothrombin time 12.6±1.1 s (normal range <13.1 s), total
bilirubin 3.5±6.4mg/dl (normal range 0–1.0mg/dl), creati-
nine 1.1±0.3mg/dl (normal range 0.6–1.3mg/dl), and
white blood cell count 9228±6452cells/mm3 (normal
range 5000–10000cell/mm3). 
Operative variables
A summary of the operations performed on those 32
patients admitted postoperatively to the SCU is shown in
Table 2. Twenty-six patients were operated upon elec-
tively and six patients emergently. Sixteen patients under-
went resection of malignant disease with curative intent, six
underwent treatment for benign disease, six had palliative
operations, and four received treatment for complications of
a surgical procedure performed during a previous hospital
admission. Mean operating time was 232±116min (median
210min, range 37–493min), mean intraoperative blood loss
was 2064±2271cm3 (median 1100cm3, range 0–9000cm3),
mean transfusion of red blood cells was 3.4±4.7units
(median 2 units, range 0–18 units), and mean intraoperative
fluid administration was 5369±3922cm3 (median 4300cm3,
range 400–20600cm3). During their postoperative course,
seven patients required second procedures (two drainage
intraabdominal abscesses, two tracheostomies, one repair of
bleeding peptic ulcer, one repair of postoperative intra-
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Table 1
Diagnoses of those 32 patients who required critical care
services during postoperative care and number of deaths by
diagnosis
Diagnosis Diagnosis [% (n)] Deaths (n)
Hepatocellular carcinoma 25 (8) 3
Pancreatic/peripancreatic malignancy 13 (4) 1
Colorectal hepatic metastases 9 (3) 1
Noncolorectal hepatic metastases 9 (3) 1
Cholangiocarcinoma 8 (3) 2
Benign biliary disease 6 (2) 0
Acute necrotizing pancreatitis 6 (2) 1
Polycystic disease of the liver 6 (2) 1
Bleeding peptic ulcer disease 6 (2) 1
Perforated peptic ulcer disease 3 (1) 1
Abdominal wall dehisence 3 (1) 0
Empyema 3 (1) 0
abdominal bleed, one repeat pancreatic debridement), two
patients required a third procedure (one repeat pancreatic
debridement, one removal of intra-abdominal packing and
closure of abdomen), and one patient required a fourth pro-
cedure (thoracotomy/decortication for empyema).
Postoperative variables and complications
The mean total stay in the SCU was 11.2±17.6days
(median 4.5days, range 1–78days). The mean postopera-
tive duration of hospital stay was 28.2±36.3days (median
15.5days, range 4–177days). Twenty-one patients were
admitted to the SCU directly from the operating room, or
the following morning from the PACU. The reason for
admission to the SCU in these 21 patients was inability to
wean from the ventilator (n=10), hypovolemic shock
(n =4), myocardial ischemia/infarction (n=2), ongoing
septic shock (n=2), ongoing upper gastrointestinal bleed-
ing (n=2), and acute renal failure (n=1). Eleven patients
were admitted to the SCU from floor care at a later time
during their postoperative course. The reasons for admis-
sion to the SCU in these 11 patients were respiratory
failure (n=4), cardiac dysrhythmia/infarction (n=4), septic
shock (n=2), and upper gastrointestinal bleeding (n=1).
Ten patients required readmission to the SCU after being
transferred to floor care (five because of upper gastroin-
testinal bleeding, five because of respiratory failures), four
patients required a third SCU admission (all because of
respiratory failures), and two patients requiring a fourth
SCU admission (both because of intra-abdominal
abscesses/sepsis). A comprehensive list of all postopera-
tive complications seen is shown in Table 3.
High and low postoperative laboratory values
Mean high and low postoperative laboratory values of the
32 patients admitted to the SCU in the postoperative
period and the mean days on which they occurred were as
follows: lowest albumin value 2.1±0.4g/dl on day 13 (±25
days), highest prothrombin time 16.7±3.0 s on day 13 (±28
days), highest total bilirubin value 6.9±6.3mg/dl on day
15 (±34 days), highest creatinine value of 1.9±1.0mg/dl
on day 13 (±17 days), and highest white blood cell count
of 20547±8467cells/mm3 on day 9 (±13 days).
Postoperative mortality
The overall postoperative mortality of all patients operated
on by the Hepatobiliary Surgical Service was 3.2% (17 out
of 537 patients). Twelve of the 32 patients (37.5%) admit-
ted to the SCU during their postoperative course died, com-
pared with five out of 505 (1.0%) patients never admitted to
the SCU during their postoperative course (P<0.001).
Neither the preoperative diagnosis (Table 1) nor the opera-
tion performed (Table 2) appear to be associated with an
increased risk of SCU death. At the time of death, eight out
of the 12 patients (67%) had respiratory failure, five patients
(42%) had hepatic failure, and three patients (25%) had
acute renal failure. Additionally, five out of the 12 patients
(42%) were septic, two patients (17%) had persistent coagu-
lopathy and ongoing upper gastrointestinal bleeding, and
two patients (17%) died of acute cardiopulmonary arrest of
undetermined etiology. Overall, three out of the 12 patients
(25%) had multiple organ system failure.
Mean total postoperative duration of stay in the SCU was
significantly longer (P=0.035) for nonsurvivors (20.0±23.8
days) than for survivors (6.2±10.2 days). Univariate
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Table 2
Type of operations performed on 32 patients admitted
requiring critical care service during postoperative care and
the number of postoperative deaths by type of operation
Type of operation Deaths
Type of operation [% (n)] (n)
Hepatic resection 47 (15) 5
Biliary enteric bypass 13 (4) 2
Pancreatic resection 9 (3) 1
Peptic ulcer operation 9 (3) 2
Extrahepatic bile duct resection 6 (2) 0
Acute pancreatitis operation 6 (2) 1
Combined hepatic and pancreatic resection 3 (1) 1
Abdominal wall dehisence 3 (1) 0
Thoracotomy and decortication 3 (1) 0
Table 3
Postoperative complications in those 32 patients who required
critical care services during postoperative care
Postoperative complications Patients [n (%)]
Respiratory failure 16 (50)
Acute renal failure 9 (28)
Bacteremia 9 (28)
Pneumonia 8 (25)
Upper gastrointestinal bleeding 8 (25)
Hepatic failure 5 (16)
Cardiac dysarrhythmias 5 (16)
Intraabdominal abscess 5 (16)
Urinary tract infection 4 (13)
Wound infection 3 (9)
Myocardial ischemia/infarction 3 (9)
Central line infection 2 (6)
Intra-abdominal bleeding 1 (3)
Empyema 1 (3)
analysis demonstrated that mortality was significantly
increased for patients who had median total postoperative
duration of stay in the SCU that was greater than the
overall median duration of stay of 4.5 days (P=0.009) and
for patients who had more than two SCU admissions
during their hospitalization (P=0.014). However, multi-
variate analysis of these variables suggested that only a
median total postoperative duration of stay in the SCU of
greater than the median total duration of stay of 4.5 days
was an independent predictor of postoperative mortality
(P=0.041). Postoperative mortality did not depend on the
total postoperative duration of stay, or on the number of
times a patient was taken to the operating room.
Preoperative and intraoperative variables were analyzed
(Table 4) as potential predictors of postoperative mortality
among patients admitted to the SCU. A history of viral
hepatitis (P=0.044) was determined to be significantly asso-
ciated with postoperative mortality among patients admitted
to the SCU by univariate analysis. By univariate analysis, the
association of history of cirrhosis/portal hypertension with
postoperative mortality was determined to approach statisti-
cal significance (P=0.053) among patients admitted to the
SCU. Multivariate analysis of those two variables revealed
that neither a history of viral hepatitis and a history of cirrho-
sis/portal hypertension was an independent predictor of post-
operative mortality among patients admitted to the SCU.
Preoperative and postoperative laboratory values
(mean±standard deviation) in survivors (n=20) and non-
survivors (n=12) were analyzed as potential predictors of
postoperative mortality among patients admitted to the
SCU (Table 5). In nonsurvivors preoperative prothrombin
time was significantly higher, preoperative albumin was
nearly significantly lower (P=0.056), postoperative pro-
thrombin time was significantly higher (P=0.021), postop-
erative albumin levels were nearly significantly lower
(P=0.055), and postoperative white blood cell count was
significantly higher (P=0.020).
Postoperative variables were analyzed as potential predic-
tors of postoperative mortality among patients admitted to
the SCU (Table 6). By univariate analysis, a patient with
postoperative pneumonia (P=0.002), hepatic failure
(P=0.004), or respiratory failure (P=0.009) was statistically
more likely to die than patients with other complications.
However, multivariate analysis of these three postopera-
tive complications failed to disclose any independent pre-
dictor of postoperative mortality.
Discussion
There is relatively incomplete information available
within the literature as to the causes and outcomes of uti-
lization of critical care services for patients undergoing
hepatobiliary surgery. In the present paper, we have
reviewed the Memorial Sloan-Kettering Cancer Center
experience during the period of February 2, 1994 to
December 28, 1995. Firstly, this study was initiated to
help to determine the causes of major morbidity and mor-
tality after hepatobiliary surgery, such that we might alter
our patient care in order to avoid similar complications in
the future. Secondly, this study was initiated to help to
evaluate possible predictors of survival once a major com-
plication had arisen, such that guidance could be given to
clinicians caring for such patients in determining the like-
lihood of ultimate survival of such events.
Over a 23-month period, 6.0% of patients operated upon
by the Hepatobiliary Surgical Service at Memorial Sloan-
Kettering Cancer Center required critical care services.
Information on similar critical care services utilized by
comparable hepatobiliary services at other institutions is
not available in the surgical literature; however, this
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Table 4
Potential preoperative and intraoperative variables associated
with postoperative mortality by univariate and multivariate
analyses in those 32 patients who required critical care






History of cirrhosis/portal hypertesion 0.053 0.194
History of viral hepatitis 0.044 0.802
History of jaundice 0.703 –
History of cardiac disease 0.718 –
Diabetes mellitus 0.999 –
Chronic obstructive pulmonary disease 0.999 –
Preoperative biliary instrumentation 0.703 –
Preoperative biliary drainage 0.999 –
Diagnosis
Hepatocellular carcinoma 0.999 –
Pancreatic/peripancreatic malignancy 0.999 –
Colorectal hepatic metastases 0.999 –
Noncolorectal hepatic metastases 0.999 –
Cholangiocarcinoma 0.540 –
Benign biliary disease 0.516 –
Polycystic disease of the liver 0.999 –
Other disease 0.999 –
Intraoperative variables
Operative time 0.999 –
Blood loss 0.999 –
Intravenous fluids 0.999 –
Transfusion of red blood cells 0.724 –
Elective versus emergency case 0.647 –
Resected for cure versus palliation 0.999 –
Hepatic resection 0.726 –
Biliary enteric bypass 0.620 –
Pancreatic resection 0.999 –
Peptic ulcer operation 0.540 –
Extrahepatic bile duct resection 0.516 –
Combined hepatic/pancreatic resection 0.375 –
Other operations 0.999 –
appears to be an appropriate level of care, because the
mortality of patients treated postoperatively with floor
care alone was only 1% (five out of 505 patients). The fact
that the mortality of hepatobiliary patients, once admitted
to the SCU, was 37.5% (12 out of 32 patients) may be
taken to suggest that patients might have been kept for
inappropriately long periods on floor care before being
admitted to a critical care setting, or that the problems that
arose were poorly treated in the critical care setting, or that
the problems that arose were beyond the ability of critical
care medicine to salvage. The latter explanation seems to
be the most probable.
The causes for admission to a critical care setting were
varied. Three findings from the present results appear to
be worth further discussing, however. First, more than
50% of the patients requiring a SCU admission suffered
respiratory failure. It is possible that instituting an
improved preoperative evaluation of pulmonary function,
as well as instituting a pulmonary rehabilitation program,
might help to reduce this excessive rate of respiratory
failure. Second, the intraoperative blood loss among
patients requiring a SCU admission was approximately
2000cm3 and the intraoperative blood transfusion require-
ment among patients requiring a SCU admission was 3.4
units of packed red blood cells. Both of these values are
well above the median values of 645cm3 of intraoperative
blood loss and less than one unit of packed red blood cells
for intraoperative blood transfusion recorded for 496
patients undergoing hepatic resection at our own institu-
tion [11]. Third, 10 out of 32 patients requiring a SCU
admission underwent preoperative biliary drainage proce-
dures, which is above the rate for all patients undergoing
hepatobiliary surgery. Our own institutional data have
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Table 5
Preoperative and postoperative laboratory values in surviving and nonsurviving patients requiring critical care services during
postoperative care
All patients Survivors Nonsurvivors
Laboratory values (n = 32) (n = 20) (n = 12) P value
Preoperative
Albumin (g/dl) 3.5 ± 0.7 3.7 ± 0.7 3.2 ± 0.7 0.056
Prothrombin time (s) 12.6 ± 1.1 12.2 ± 0.9 13.1 ± 1.2 0.025
Total bilirubin (mg/dl) 3.5 ± 6.4 4.5 ± 7.6 1.8 ± 3.4 0.263
Creatinine (mg/dl) 1.1 ± 0.3 1.1 ± 0.3 1.0 ± 0.4 0.263
White blood cells (cells/mm³) 9228 ± 6452 8005 ± 3384 11 267 ± 9501 0.170
Postoperative
Albumin low (g/dl) 2.1 ± 0.4 2.2 ± 0.5 1.9 ± 0.4 0.055
Prothrombin time high (s) 16.7 ± 3.0 15.8 ± 2.6 18.3 ± 3.1 0.021
Total bilirubin high (mg/dl) 6.9 ± 6.3 6.9 ± 7.5 6.9 ± 3.6 0.998
Creatinine high (mg/dl) 1.9 ± 1.0 1.6 ± 0.8 2.2 ± 1.3 0.102
White blood cells high (cells/mm³) 20 547 ± 8467 17 905 ± 6055 24 950 ± 10 240 0.020
Values are expressed as means ± standard deviation.
Table 6
Potential postoperative complications associated with
postoperative mortality by univariate and multivariate analyses
in those 32 patients who required critical care services during
postoperative care
Univariate Multivariate
Postoperative complications (P) (P)
Respiratory failure 0.009 0.093
Bacteremia 0.696 –
Pneumonia 0.002 0.239
Upper gastrointestinal bleeding 0.116 –
Acute renal failure 0.696 –
Hepatic failure 0.004 0.863
Cardiac dysarrhythmias 0.130 –
Intra-abdominal abscess 0.999 –
Wound infection 0.999 –
Urinary tract infection 0.136 –
Myocardial ischemia/infarction 0.274 –
Central line infection 0.999 –
Intra-abdominal bleeding 0.999 –
Empyema 0.375 –
shown that previously drained patients with tumors
causing proximal or distal obstruction of the biliary tree
who undergo surgical resection or surgical bypass suffer
increased intraoperative blood loss [12], as well as
increased postoperative infectious complications [13–16].
Those organisms responsible for the postoperative infec-
tious complications were the same as those organisms iso-
lated from intraoperative bile cultures [14,16–18]. This
suggests that the potential benefit of preoperative
drainage of the biliary tree before surgical resection is
questionable and needs to be evaluated further.
On univariate analysis, we found an association of a history
of viral hepatitis with postoperative mortality (P=0.044)
and a near association of a history of cirrhosis (with or
without portal hypertension) with postoperative mortality
(P=0.053). These findings confirm the prior reports of
Bozzetti et al [1] and Lehnert and Herfarth [19]. Likewise,
we found that preoperative prothrombin time was signifi-
cantly (P=0.025) higher in the nonsurviving patients
versus the surviving patients who required postoperative
critical care utilization, and preoperative albumin was
nearly significantly (P=0.056) lower in the nonsurviving
patients versus the surviving patients who required post-
operative critical care utilization. These findings confirm
the prior reports of Nagino et al [6], Su et al [7], and
Lehnert and Herfarth [19]. Although these associations
were not independent predictors of postoperative mortal-
ity on multivariate analysis, these associations suggest the
importance of hepatic function and hepatic reserve in pre-
operative patient selection for hepatobiliary surgery, as has
been previously established by the Child–Turcotte–Pugh
grading system for severity of liver disease [20,21]. None
of the thirty-two patients requiring postoperative SCU
admission had ascites or were encephalopathic preopera-
tively. Therefore, preoperative prothrombin time and pre-
operative albumin, as well as a history of viral hepatitis
and/or a history of cirrhosis with or without portal hyper-
tension, may be taken to indicate a need for heightened
alertness to the possibility of the need for critical care ser-
vices after significant hepatobiliary surgery.
Once admitted to the critical care unit, postoperative mor-
tality increased with increasing duration of stay, with
patients whose SCU stays exceeded 4.5 days doing signifi-
cantly worse. Beyond this association of survival and dura-
tion of SCU stay, we were unable to establish any distinct
individual markers to help determine the appropriateness
of continuing aggressive care of critically ill patients.
However, if markers could be identified, then the deter-
mination of the time at which aggressive critical care
becomes futile could be established. This would ulti-
mately better assist the critical care staff in advising the
patient or proxy as to when survival is unlikely, and all
subsequent decisions about pursuing further aggressive
interventions could be made with this in mind.
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